Temozolomide (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the Temozolomide drug offered from Sun Pharma Global FZE. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
| NON-PROPRIETARY NAME: | Temozolomide |
| SUBSTANCE NAME: | TEMOZOLOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-02-13 |
| END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Temozolomide from Sun Pharma Global FZE |
| LABELER NAME: | Sun Pharma Global FZE |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2014-02-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47335-890_d2cd19c6-f068-4e46-a2a4-89eabc97f1dc |
| PRODUCT NDC: | 47335-890 |
| APPLICATION NUMBER: | ANDA201742 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers:
